Inventor · disambiguated record
Jing Qing
Also filed as: QING JING
8 granted patents·5 pending applications·56 citations·filing 2010–2023
87Inventor score
Top patents by PatentIndex Score
13 records- 0192US8710189B2Anti-FGFR3 antibodies and methods using sameGENENTECH INC·Filed 2012·Granted Apr 29, 2014·12 cites·10 claims
- 0292US8410250B2Anti-FGFR3 antibodies and methods using sameASHKENAZI AVI·Filed 2010·Granted Apr 2, 2013·23 cites·27 claims
- 0390US10000571B2Anti-FGFR3 antibodies and methods using sameGENENTECH INC·Filed 2016·Granted Jun 19, 2018·6 cites·11 claims
- 0490US9499623B2Anti-FGFR3 antibodies and methods using sameGENENTECH INC·Filed 2015·Granted Nov 22, 2016·6 cites·24 claims
- 0584US9161977B2Anti-FGFR3 antibodies and methods using sameGENENTECH INC·Filed 2013·Granted Oct 20, 2015·4 cites·11 claims
- 0680US11401333B2Anti-FGFR3 antibodies and methods using sameGENENTECH INC·Filed 2019·Granted Aug 2, 2022·1 cites·13 claims
- 0778US10287356B2Anti-FGFR3 antibodies and methods using sameGENENTECH INC·Filed 2016·Granted May 14, 2019·1 cites·9 claims
- 0869US9358250B2Methods of using SCD1 antagonistsGENENTECH INC·Filed 2012·Granted Jun 7, 2016·3 cites·23 claims
- 0965US2014187754A1Anti-fgfr3 antibodies and methods using sameGENENTECH INC·Filed 2014·Application pending·0 cites
- 1056US2018280505A1Methods and compositions for treating cancer using pd-1 axis antagonists and hpk1 antagonistsGENENTECH INC·Filed 2018·Application pending·0 cites
- 1150US2016158360A1Methods and compositions for treating cancer using pd-1 axis antagonists and hpk1 antagonistsGENENTECH INC·Filed 2015·Application pending·0 cites
- 1250US2024010595A1Method for synthesizing labeled pyruvic acidSHENZHEN ZHONGHE HEADWAY BIO SCI & TECH CO LTD·Filed 2023·Application pending·0 cites
- 1345US2023124002A1Continuous-flow synthesis method of 13c-ureaSHENZHEN ZHONGHE HEADWAY BIO SCI & TECH CO LTD·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jing Qing files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →